Viewing Study NCT01787669

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:46 PM
Ignite Modification Date: 2026-02-20 @ 8:19 AM
Study NCT ID: NCT01787669
Status: COMPLETED
Last Update Posted: 2018-11-13
First Post: 2013-02-06
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema
Sponsor: University of Sydney
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes View
None Diabetic Macular Oedema View
None Diabetic Macular Edema View
None Diabetic Retinopathy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None diabetic macular oedema View
None diabetic macular edema View
None diabetic retinopathy View
None dexamethasone View
None Ozurdex View
None Avastin View
None bevacizumab View
None DME View
None DMO View